Published Global mergers and acquisitions (M&A) activity is surging, especially in the pharmaceutical and semiconductor sectors. In these industries, intellectual property – not physical factories – drives most company value. Pharmaceutical firms eyeing patent...
Published How leading life sciences IP teams are adapting to complexity, risk, and rapid change Download the full report to access detailed insights, practitioner perspectives, and best practices shaping IP strategy in life sciences today: Insights and Best Practices...
Published Since 2005, Open Invention Network (OIN) has continued in its mission of protecting and promoting open source software (OSS) from patent threats. Its efforts have shielded the open source community from patent aggression, enabling new kinds of industries to...
Published By 2026, artificial intelligence will no longer be a “nice to have” in corporate IP departments. It will be a baseline requirement for managing invention capture, patent quality, portfolio scale, and legal risk. That transition is already well underway. A...
Published For most large R&D-driven organizations, the biggest innovation risk is not competitors—it is silence. Every year, thousands of potentially patentable inventions never make it into an invention disclosure, let alone a patent filing. They remain buried in...
Published AI adoption isn’t just a passing trend; it is an irreversible shift in human productivity and creativity. We have moved beyond simple processing into an era of generative partnership. For the first time, our tools do more than organize data – they...
